BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24408046)

  • 1. Diffusion-weighted magnetic resonance imaging in the prediction and assessment of chemotherapy outcome in liver metastases.
    Mungai F; Pasquinelli F; Mazzoni LN; Virgili G; Ragozzino A; Quaia E; Morana G; Giovagnoni A; Grazioli L; Colagrande S
    Radiol Med; 2014 Aug; 119(8):625-33. PubMed ID: 24408046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
    Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
    J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
    Schmeel FC; Simon B; Luetkens JA; Träber F; Meyer C; Schmeel LC; Sabet A; Ezziddin S; Schild HH; Hadizadeh DR
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1531-1541. PubMed ID: 28317063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Treatment Response of Colorectal Cancer Liver Metastases to Conventional Lipiodol-Based Transarterial Chemoembolization Using Diffusion-Weighted MR Imaging: Value of Pretreatment Apparent Diffusion Coefficients (ADC) and ADC Changes Under Therapy.
    Lahrsow M; Albrecht MH; Bickford MW; Vogl TJ
    Cardiovasc Intervent Radiol; 2017 Jun; 40(6):852-859. PubMed ID: 28357571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting liver metastasis of gastrointestinal tract cancer by diffusion-weighted imaging of apparent diffusion coefficient values.
    Zheng DX; Meng SC; Liu QJ; Li CT; Shang XD; Zhu YS; Bai TJ; Xu SM
    World J Gastroenterol; 2016 Mar; 22(10):3031-7. PubMed ID: 26973399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apparent diffusion coefficient measurements as very early predictive markers of response to chemotherapy in hepatic metastasis: a preliminary investigation of reproducibility and diagnostic value.
    Deckers F; De Foer B; Van Mieghem F; Botelberge T; Weytjens R; Padhani A; Pouillon M
    J Magn Reson Imaging; 2014 Aug; 40(2):448-56. PubMed ID: 24924334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Early Response to Chemotherapy in Breast Cancer Liver Metastases by Diffusion-Weighted MR Imaging.
    Bai G; Wang Y; Zhu Y; Guo L
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819842944. PubMed ID: 30961445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equivalent cross-relaxation rate imaging and diffusion weighted imaging for early prediction of response to bevacizumab-containing treatment in colorectal liver metastases-preliminary study.
    Matsushima S; Sato T; Nishiofuku H; Sato Y; Murata S; Kinosada Y; Era S; Inaba Y
    Clin Imaging; 2017; 41():1-6. PubMed ID: 27721090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3T diffusion-weighted MRI in the response assessment of colorectal liver metastases after chemotherapy: Correlation between ADC value and histological tumour regression grading.
    Donati F; Boraschi P; Pacciardi F; Cervelli R; Castagna M; Urbani L; Falaschi F; Caramella D
    Eur J Radiol; 2017 Jun; 91():57-65. PubMed ID: 28629572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma.
    Chen Y; Liu X; Zheng D; Xu L; Hong L; Xu Y; Pan J
    Magn Reson Imaging; 2014 Jul; 32(6):630-7. PubMed ID: 24703576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases.
    Liang HY; Huang YQ; Yang ZX; Ying-Ding ; Zeng MS; Rao SX
    Eur Radiol; 2016 Jul; 26(7):2009-18. PubMed ID: 26494642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of MR diffusion-weighted imaging in diagnosis and outcome prediction for uterine cervical cancer].
    Wu B; Huang X; Peng W; Gu Y; Yang T; Mao J; Ke G; Wu X
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):115-9. PubMed ID: 24796459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma: response to TACE assessed with semiautomated volumetric and functional analysis of diffusion-weighted and contrast-enhanced MR imaging data.
    Bonekamp S; Jolepalem P; Lazo M; Gulsun MA; Kiraly AP; Kamel IR
    Radiology; 2011 Sep; 260(3):752-61. PubMed ID: 21771960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of intravoxel incoherent motion imaging, diffusion kurtosis imaging, and conventional DWI in predicting the chemotherapeutic response of colorectal liver metastases.
    Zhang H; Li W; Fu C; Grimm R; Chen Z; Zhang W; Qiu L; Wang C; Zhang X; Yue L; Hu X; Guo W; Tong T
    Eur J Radiol; 2020 Sep; 130():109149. PubMed ID: 32659615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal liver metastases: ADC as an imaging biomarker of tumor behavior and therapeutic response.
    Boraschi P; Donati F; Cervelli R; Pacciardi F; Tarantini G; Castagna M; Urbani L; Lencioni R
    Eur J Radiol; 2021 Apr; 137():109609. PubMed ID: 33647779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic treatment of the metastatic renal cell carcinoma: usefulness of the apparent diffusion coefficient of diffusion-weighted MRI in prediction of early therapeutic response.
    Mytsyk Y; Pasichnyk S; Dutka I; Dats I; Vorobets D; Skrzypczyk M; Uteuliyev Y; Botikova A; Gazdikova K; Kubatka P; Urdzik P; Kruzliak P
    Clin Exp Med; 2020 May; 20(2):277-287. PubMed ID: 32026157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion-Weighted MR Imaging of Primary and Secondary Lung Cancer: Predictive Value for Response to Transpulmonary Chemoembolization and Transarterial Chemoperfusion.
    Vogl TJ; Hoppe AT; Gruber-Rouh T; Basten L; Dewes P; Hammerstingl RM; Balaban Ü; Mastrodicasa D; Thompson ZM; Albrecht MH
    J Vasc Interv Radiol; 2020 Feb; 31(2):301-310. PubMed ID: 31899107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of diffusion weighted MR imaging as an early surrogate parameter for evaluation of tumor response to high-dose-rate brachytherapy of colorectal liver metastases.
    Wybranski C; Zeile M; Löwenthal D; Fischbach F; Pech M; Röhl FW; Gademann G; Ricke J; Dudeck O
    Radiat Oncol; 2011 Apr; 6(1):43. PubMed ID: 21524305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy.
    Wang L; Liu L; Han C; Liu S; Tian H; Li Z; Ren X; Shi G; Wang Q; Wang G
    Radiother Oncol; 2016 Nov; 121(2):246-251. PubMed ID: 27838148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
    Park SH; Moon WK; Cho N; Song IC; Chang JM; Park IA; Han W; Noh DY
    Radiology; 2010 Oct; 257(1):56-63. PubMed ID: 20851939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.